4 January 2016Willfact behaves in the same way as endogenous von Willebrand factor
Willfactvon Willebrand disease
New molecular entity
Development and Regulatory status
Jan 21Available in UK. Price 1000iu per 10mL vial, 1=£922 .
Jan 11Approved in UK for prevention and treatment of haemorrhages or surgical bleeding in von Willebrand disease when desmopressin (DDAVP) treatment alone is ineffective or contraindicated .
Willfact behaves in the same way as endogenous von Willebrand factor
Prevalence is as high as 1-2% in the general population on unselected screening. Worldwide incidence is around 125 per million with between 0.5 and 5 per million being severely affected. Most people have mild disease .
von Willebrand disease